[1]
“Evaluation of safety and efficacy of Unani Add-on regimen in preventing the progression of severity of the disease in hospitalized SARS-CoV2 tested positive asymptomatic /mild to moderate symptomatic COVID-19 cases- A Randomised Controlled Clinical Trial”, Bangladesh J Med Sci, vol. 21, no. 4, pp. 901–911, Sep. 2022, doi: 10.3329/bjms.v21i4.60290.